World's Best Scientists 2026 revealed!
Clinical Genitourinary Cancer
H-index 26

Clinical Genitourinary Cancer

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 858 271 363 25

Additional Metrics

Number of Best Scientists*: 323
Documents by Best Scientists*: 400
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 59
SCIMAGO SJR: 1.13
Impact Factor: 2.7

Overview

Top Research Topics at Clinical Genitourinary Cancer?

Clinical Genitourinary Cancer primarily focuses on research topics in Internal medicine, Oncology, Prostate cancer, Renal cell carcinoma and Urology. The study on Internal medicine presented is investigated in conjunction with research in Surgery. Topics like Retrospective cohort study and Survival analysis are tackled as part of the discussions on Surgery.

The journal addresses concerns in the field of Oncology by exploring it in line with topics in Confidence interval which intersect with Odds ratio subjects. Prostate cancer research featured in it incorporates concerns from various other topics such as Prostate and Docetaxel. Topics in Renal cell carcinoma were tackled in line with various other fields like Targeted therapy, Carcinoma and Nephrectomy.

Cystectomy and Cohort are some topics wherein Urology research discussed in it have an impact. Most of the Cancer studies addressed also intersect with Stage (cooking). It focused on Hazard ratio research but expanded to cover Gastroenterology.

  • Internal medicine (58.59%)
  • Oncology (45.33%)
  • Prostate cancer (32.88%)

What are the most cited papers published in the journal?

  • Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma (170 citations)
  • Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma. (152 citations)
  • Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy (147 citations)

Research areas of the most cited articles at Clinical Genitourinary Cancer:

The most cited articles are organized to address concerns in the fields of Internal medicine, Oncology, Prostate cancer, Renal cell carcinoma and Surgery. The study of Oncology in the published papers encompasses disciplines such as Pathology, as well as fields such as Cancer research, all of which overlap with one another. Prostate, Docetaxel and Urology are some topics wherein Prostate cancer research discussed in the journal articles has an impact.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Surgery

The previous edition focused in particular on these issues:

The journal aims to foster the development of research in Internal medicine, Oncology, Prostate cancer, Renal cell carcinoma and Cancer. The Oncology works featured in the journal incorporate elements from Pembrolizumab, Adverse effect, Retrospective cohort study, Disease and Stage (cooking). The research on Prostate cancer featured in it combines topics in other fields like Radiology and Metastasis.

The work on Renal cell carcinoma tackled in Clinical Genitourinary Cancer brings together disciplines like Nausea and Nivolumab. The research on Cancer tackled can also make contributions to studies in the areas of Biopsy and Logistic regression. While the primary focus in it is Chemotherapy, it also dissects topics surrounding Bladder cancer and Urology as a whole.

The most cited articles from the last journal are:

  • Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness (16 citations)
  • Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study. (10 citations)
  • Impact of COVID-19 Pandemic on Health-Related Quality of Life in Uro-oncologic Patients: What Should We Wait For? (9 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Genitourinary Cancer (based on the number of publications) are:

  • Shahrokh F. Shariat (52 papers) published 7 papers at the last edition, 5 less than at the previous edition,
  • Guru Sonpavde (46 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Toni K. Choueiri (41 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Brian I. Rini (41 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Alberto Briganti (40 papers) published 5 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Genitourinary Cancer (based on the number of publications) are:

  • Harvard University (127 papers) published 10 papers at the last edition, 3 more than at the previous edition,
  • Cleveland Clinic (75 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (69 papers) published 8 papers at the last edition,
  • Memorial Sloan Kettering Cancer Center (67 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Vita-Salute San Raffaele University (51 papers) published 5 papers at the last edition, 9 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.73% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.95% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.80% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.86% of all publications and 45.39% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Interdisciplinary Approaches in Clinical Genitourinary Cancer

Integrative and interdisciplinary approaches contribute significantly to the in-depth understanding and treatment of genitourinary cancers. Clinical Genitourinary Cancer often publishes research that draws from various scientific and medical disciplines for holistic insights into treatment approaches. Such interdisciplinary approaches could span from mix of biology, medicine and technology, which together could enhance our understanding of cancer at a molecular level and aid in the development of targeted therapies.

Furthermore, these integrative approaches often branch out into providing better educational resources for those who wish to delve deeper in the field. For instance, online nursing schools offer comprehensive programs that include multidisciplinary curriculums, enablign students to gain an extensive understanding of genitourinary cancers and their treatment. This interdisciplinary approach not only fosters a deeper understanding of genitourinary cancers but also equips future healthcare professionals with the knowledge and skills needed to provide efficient patient care.

Top Publications

  • Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

    Daniel J. George;Oliver Sartor;Kurt Miller;Fred Saad

    (2020)
    138 Citations
  • Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.

    Joshua J. McFarlane;Mark D. Kochenderfer;Mark R. Olsen;Todd M. Bauer

    (2020)
    84 Citations
  • Sex Differences in Urothelial Bladder Cancer Survival.

    Cecilia Radkiewicz;Gustaf Edgren;Anna Louise Viktoria Johansson;Staffan Jahnson

    (2020)
    51 Citations
  • Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma.

    Ruby Gupta;Moshe Chaim Ornstein;Hong Li;Kimberly D. Allman

    (2020)
    51 Citations
  • Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities.

    Marina Deuker;Thomas Martin;Franziska Stolzenbach;Giuseppe Rosiello

    (2021)
    45 Citations
  • Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.

    Panagiotis Zoumpourlis;Giannicola Genovese;Nizar M. Tannir;Pavlos Msaouel;Pavlos Msaouel

    (2021)
    42 Citations
  • Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.

    Jack V.W. Bacon;Matti Annala;Maryam Soleimani;Jean-Michel Lavoie

    (2020)
    41 Citations
  • Neoadjuvant Gemcitabine-Cisplatin plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: a 12-year experience

    Gopa Iyer;Gopa Iyer;Christopher M. Tully;Emily C. Zabor;Bernard H. Bochner

    (2020)
    38 Citations
  • Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials.

    Lorenzo Marconi;Maxine Sun;Christian Beisland;Tobias Klatte

    (2021)
    35 Citations
  • Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.

    (2020)
    35 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their healthcare knowledge beyond medicine, numerous online programs offer flexible learning options. Careers in healthcare administration are growing rapidly, and pursuing health administration degrees online can open doors to management roles in hospitals, clinics, and public health organizations.

Nursing remains a vital field within healthcare, with many professionals advancing their careers through specialized programs. The availability of affordable online nursing programs allows students to earn degrees while balancing work and personal commitments. For those focused on clinical leadership, online nurse practitioner programs offer pathways to advanced practice roles with greater responsibility and independence.

Furthermore, continuing education options such as the cheapest bsn to dnp programs enable registered nurses to reach doctoral-level expertise efficiently and affordably. These programs are essential for those aiming at the highest levels of clinical practice and leadership in healthcare settings.

Exploring these related online degrees can provide valuable career pathways and complement a background in medicine, ensuring diverse opportunities within the evolving healthcare landscape.

Best Scientists Contributing to This Journal

Recently Published Articles